Matches in SemOpenAlex for { <https://semopenalex.org/work/W3210431175> ?p ?o ?g. }
- W3210431175 endingPage "614" @default.
- W3210431175 startingPage "614" @default.
- W3210431175 abstract "Models created by the intraperitoneal injection of lipopolysaccharide (LPS) and D-galactosamine (D-GalN) have been widely used to study the pathogenesis of human acute liver failure (ALF) and drug development. Our previous study reported that oyster (Crassostrea gigas) hydrolysate (OH) had a hepatoprotective effect in LPS/D-GalN-injected mice. This study was performed to identify the hepatoprotective effect of the tyrosine-alanine (YA) peptide, the main component of OH, in a LPS/D-GalN-injected ALF mice model. We analyzed the effect of YA on previously known mechanisms of hepatocellular injury in the model. LPS/D-GalN-injected mice showed inflammatory, apoptotic, ferroptotic, and pyroptotic liver injury. The pre-administration of YA (10 mg/kg or 50 mg/kg) significantly reduced the liver damage factors. The hepatoprotective effect of YA was higher in the 50 mg/kg YA pre-administered group than in the 10 mg/kg YA pre-administered group. These results showed that YA had a hepatoprotective effect by reducing inflammation, apoptosis, ferroptosis, and pyroptosis in the LPS/D-GalN-injected ALF mouse model. We suggest that YA can be used as a functional peptide for the prevention of acute liver injury." @default.
- W3210431175 created "2021-11-08" @default.
- W3210431175 creator A5002369637 @default.
- W3210431175 creator A5004479136 @default.
- W3210431175 creator A5017352089 @default.
- W3210431175 creator A5021046528 @default.
- W3210431175 creator A5024545260 @default.
- W3210431175 creator A5048206942 @default.
- W3210431175 creator A5055830493 @default.
- W3210431175 creator A5060125662 @default.
- W3210431175 creator A5088574413 @default.
- W3210431175 creator A5091214693 @default.
- W3210431175 creator A5091466840 @default.
- W3210431175 creator A5091703720 @default.
- W3210431175 date "2021-10-28" @default.
- W3210431175 modified "2023-10-14" @default.
- W3210431175 title "Oyster-Derived Tyr-Ala (YA) Peptide Prevents Lipopolysaccharide/D-Galactosamine-Induced Acute Liver Failure by Suppressing Inflammatory, Apoptotic, Ferroptotic, and Pyroptotic Signals" @default.
- W3210431175 cites W1416364033 @default.
- W3210431175 cites W1932854961 @default.
- W3210431175 cites W1974131542 @default.
- W3210431175 cites W1976087328 @default.
- W3210431175 cites W1979315534 @default.
- W3210431175 cites W2021246671 @default.
- W3210431175 cites W2037291767 @default.
- W3210431175 cites W2047244907 @default.
- W3210431175 cites W2049923191 @default.
- W3210431175 cites W2050280213 @default.
- W3210431175 cites W2052458771 @default.
- W3210431175 cites W2053451322 @default.
- W3210431175 cites W2054058508 @default.
- W3210431175 cites W2066538173 @default.
- W3210431175 cites W2081766673 @default.
- W3210431175 cites W2097903382 @default.
- W3210431175 cites W2112610029 @default.
- W3210431175 cites W2121069280 @default.
- W3210431175 cites W2153770500 @default.
- W3210431175 cites W2153940185 @default.
- W3210431175 cites W2159750628 @default.
- W3210431175 cites W2163476992 @default.
- W3210431175 cites W2165626477 @default.
- W3210431175 cites W2187338415 @default.
- W3210431175 cites W2265062179 @default.
- W3210431175 cites W2317513264 @default.
- W3210431175 cites W2341254086 @default.
- W3210431175 cites W2587965407 @default.
- W3210431175 cites W2600722830 @default.
- W3210431175 cites W2734829899 @default.
- W3210431175 cites W2735527928 @default.
- W3210431175 cites W2768673651 @default.
- W3210431175 cites W2794703348 @default.
- W3210431175 cites W2801891815 @default.
- W3210431175 cites W2810635715 @default.
- W3210431175 cites W2893909390 @default.
- W3210431175 cites W2907449531 @default.
- W3210431175 cites W2945470974 @default.
- W3210431175 cites W2972923507 @default.
- W3210431175 cites W2989578187 @default.
- W3210431175 cites W2999148392 @default.
- W3210431175 cites W3002300102 @default.
- W3210431175 cites W3006488526 @default.
- W3210431175 cites W3006690479 @default.
- W3210431175 cites W3022601572 @default.
- W3210431175 cites W3035952223 @default.
- W3210431175 cites W3041162284 @default.
- W3210431175 cites W3087617819 @default.
- W3210431175 cites W3090639473 @default.
- W3210431175 cites W3091844804 @default.
- W3210431175 cites W3121559483 @default.
- W3210431175 cites W3124747782 @default.
- W3210431175 cites W3138014196 @default.
- W3210431175 cites W3169906663 @default.
- W3210431175 cites W4242966060 @default.
- W3210431175 doi "https://doi.org/10.3390/md19110614" @default.
- W3210431175 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8624370" @default.
- W3210431175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34822485" @default.
- W3210431175 hasPublicationYear "2021" @default.
- W3210431175 type Work @default.
- W3210431175 sameAs 3210431175 @default.
- W3210431175 citedByCount "14" @default.
- W3210431175 countsByYear W32104311752022 @default.
- W3210431175 countsByYear W32104311752023 @default.
- W3210431175 crossrefType "journal-article" @default.
- W3210431175 hasAuthorship W3210431175A5002369637 @default.
- W3210431175 hasAuthorship W3210431175A5004479136 @default.
- W3210431175 hasAuthorship W3210431175A5017352089 @default.
- W3210431175 hasAuthorship W3210431175A5021046528 @default.
- W3210431175 hasAuthorship W3210431175A5024545260 @default.
- W3210431175 hasAuthorship W3210431175A5048206942 @default.
- W3210431175 hasAuthorship W3210431175A5055830493 @default.
- W3210431175 hasAuthorship W3210431175A5060125662 @default.
- W3210431175 hasAuthorship W3210431175A5088574413 @default.
- W3210431175 hasAuthorship W3210431175A5091214693 @default.
- W3210431175 hasAuthorship W3210431175A5091466840 @default.
- W3210431175 hasAuthorship W3210431175A5091703720 @default.
- W3210431175 hasBestOaLocation W32104311751 @default.
- W3210431175 hasConcept C17172800 @default.
- W3210431175 hasConcept C185592680 @default.
- W3210431175 hasConcept C190283241 @default.